Kuehn Law, PLLC is investigating whether certain officers and directors of iRhythm Technologies, Inc. breached their fiduciary duties to shareholders. The investigation stems from a federal securities lawsuit alleging that insiders caused the company to misrepresent or fail to disclose that the Zio AT monitor was a real-time monitor intended for high-risk patients, and that they touted its growth potential as an innovative product just beginning to penetrate the real-time monitoring market. These misrepresentations allegedly caused iRhythm common stock to trade at artificially inflated prices. Shareholders who currently own IRTC and purchased prior to November 5, 2021 are encouraged to contact the firm immediately, as there may be limited time to enforce their rights.
iRhythm Technologies IncInvestigation and lawsuit for alleged misrepresentations about Zio AT monitor, causing artificially inflated stock price.